The global Dental Membrane And Bone Graft Substitute Market is estimated to be valued at US$ 1143.56 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Dental membrane and bone graft substitutes are surgical implants used in dental procedures like dental extraction, periodontal defect reconstruction, ridge augmentation and alveolar ridge preservation. They act as a scaffold and enhance tissue regeneration.
Market key trends:
One of the key trends in the dental membrane and bone graft substitute market is the rising preference for tissue regeneration among dental surgeons and patients. Tissue regeneration has gained popularity over extraction due to its ability to preserve natural structures of teeth and jawbone along with improved function and esthetics. Membrane and graft substitutes are widely used in tissue regeneration as they facilitate new bone formation, guide cell behaviors and provide structural support for tissue regrowth. Demand for membrane and graft substitutes has increased significantly owing to their effectiveness in regenerating lost periodontal structures.
The dental membrane and bone graft substitute market is dominated by the allograft sub-segment due to its high biocompatibility and osteoconductive properties. Allografts contain growth factors that promote bone formation and healing. Synthetic grafts are also gaining popularity owing to their unlimited supply and lack of disease transmission risk.
The global dental membrane and bone graft substitute market is expected to witness high growth, exhibiting a CAGR of 9.4% over the forecast period, due to increasing prevalence of dental diseases and rising demand for dental procedures.
North America dominates the global market due to increased awareness regarding oral healthcare and rise in dental tourism. Europe is expected to be the fastest growing region owing to growing prevalence of periodontal and tooth-related diseases.
The global dental membrane and bone graft substitute market size was valued at US$ 1143.56 Mn in 2023 and is expected to reach over US$ 2218.92 Mn by 2030.
Key players operating in the dental membrane and bone graft substitute market include Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp. These leading manufacturers are focusing on new product launches and strategic collaborations to strengthening their presence in the market.